- Home
- GNLX vs RFM Comparison
GNLX vs RFM Comparison
Compare GNLX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.66
Company Overview
Basic Information| Metric | GNLX | RFM |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.8M | 89.6M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GNLX | RFM |
|---|---|---|
| Price | $2.66 | $14.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 150.4K | 24.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.10 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $13.14 |
| 52 Week High | $8.54 | $15.28 |
Technical Indicators
Market Signals| Indicator | GNLX | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 43.94 | 43.96 |
| Support Level | $2.54 | $14.14 |
| Resistance Level | $2.80 | $14.53 |
| Average True Range (ATR) | 0.17 | 0.16 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 17.20 | 27.59 |
Price Performance
Historical Comparison GNLX
RFM
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.